The DOI matches its Crossref record; 80 of the 82 references it cites were found in a registry or an index.
International Consensus on Use of Continuous Glucose Monitoring
Open accessAbstract
Measurement of glycated hemoglobin (HbA1c) has been the traditional method for assessing glycemic control. However, it does not reflect intra- and interday glycemic excursions that may lead to acute events (such as hypoglycemia) or postprandial hyperglycemia, which have been linked to both microvascular and macrovascular complications. Continuous glucose monitoring (CGM), either from real-time use (rtCGM) or intermittently viewed (iCGM), addresses many of the limitations inherent in HbA1c testing and self-monitoring of blood glucose. Although both provide the means to move beyond the HbA1c measurement as the sole marker of glycemic control, standardized metrics for analyzing CGM data are lacking. Moreover, clear criteria for matching people with diabetes to the most appropriate glucose monitoring methodologies, as well as standardized advice about how best to use the new information they provide, have yet to be established. In February 2017, the Advanced Technologies & Treatments for Diabetes (ATTD) Congress convened an international panel of physicians, researchers, and individuals with diabetes who are expert in CGM technologies to address these issues. This article summarizes the ATTD consensus recommendations and represents the current understanding of how CGM results can affect outcomes.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“In many countries, the benefits and utility of CGM are now recognized by national and international medical organizations for individuals with insulin-requiring diabetes and/or those at risk for hypoglycemia (16-21).”
From Clinical Targets for Continuous Glucose Monitoring Data Interpretation: Recommendations From the International Consensus on Time in Range (2019) · cites this paper as [18]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Correlations of fructosamine with HbA1c and mean blood glucose were examined in 4 observational studies.”
From KDIGO 2022 Clinical Practice Guideline for Diabetes Management in Chronic Kidney Disease (2022) · cites this paper as [198]
Experimental — accuracy not yet measuredThe cited source says what the claim attributes to it.
In the citing paper
“The list of core CGM metrics has now been streamlined for use in clinical practice based on the expert opinion of this International Consensus Group (18).”
From Clinical Targets for Continuous Glucose Monitoring Data Interpretation: Recommendations From the International Consensus on Time in Range (2019) · cites this paper as [18]
The cited source says what the claim attributes to it.
In the citing paper
“This recommendation was later endorsed at the aforementioned international consensus conference on CGM metrics (18) and is referenced as an example in the American Diabetes Association (ADA) 2019 Standards of Care (16) and in an update to the American Association of Clinical Endocrinologists (AACE) consensus on use of CGM (69).”
From Clinical Targets for Continuous Glucose Monitoring Data Interpretation: Recommendations From the International Consensus on Time in Range (2019) · cites this paper as [18]
The cited source says what the claim attributes to it.
In the citing paper
“CGM helps characterize the timing, amplitude, and frequency of excursions [133–139], and provides quantitative metrics such as TIR, time in hypoglycemia (TBR) and hyperglycemia (TAR), and indices of glycemic variability, which are increasingly used as clinically meaningful targets in diabetes management [140–144].”
From Diabetic gastroparesis: pathophysiology and impact on insulin timing choices (2026) · cites this paper as [133]
The cited source says what the claim attributes to it.
In the citing paper
“In this context, CGM plays a central role by enabling visualization of glycemic trends and revealing patterns that are missed with capillary glucose testing [132, 133].”
From Diabetic gastroparesis: pathophysiology and impact on insulin timing choices (2026) · cites this paper as [133]
The cited source says what the claim attributes to it.
In the citing paper
“Our findings support the recent consensus conference recommendation (12, 13) that sensor glucose values ,54 mg/dL represent a more meaningful cut-off than 70 mg/dL to define clinically important hypoglycemia because CGM glucose levels below 54 mg/dL were uncommon, whereas most participants had some glucose levels of 55 to 69 mg/dL.”
From Continuous Glucose Monitoring Profiles in Healthy Nondiabetic Participants: A Multicenter Prospective Study (2019) · cites this paper as [12]
The cited source says what the claim attributes to it.
In the citing paper
“The current consensus conferences have somewhat arbitrarily set time in ranges for CGM sensor glucose levels for patients with T1D, with time in target identified as being between 70 to 180 mg/dL (12,13).”
From Continuous Glucose Monitoring Profiles in Healthy Nondiabetic Participants: A Multicenter Prospective Study (2019) · cites this paper as [12]
In the citing paper
“Core glucose metrics determined by CGM, including TIR and GMI, provide more precise real-time and retrospective information about glycemic control.34”
From Glucose time in range and peripheral neuropathy in type 2 diabetes mellitus and chronic kidney disease (2020) · cites this paper as [34]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
(1993) · New England Journal of Medicine · doi:10.1056/nejm199309303291401 · Cited by 24,667
10-year follow-up of intensive glucose control in type 2 diabetes
Holman, R. R., Paul, S. K., Bethel, M. A., Matthews, D. R., & Neil, H. A. W. (2008) · New England Journal of Medicine · doi:10.1056/nejmoa0806470 · Cited by 7,751
Monnier, L., Mas, E., Ginet, C., Michel, F., Villon, L., Cristol, J.-P., & Colette, C. (2006) · JAMA · doi:10.1001/jama.295.14.1681 · Cited by 2,444
Standards of Medical Care in Diabetes—2009
American Diabetes Association (2009) · Diabetes Care · doi:10.2337/dc09-s013 · Cited by 2,167
Beck, R. W., Riddlesworth, T., Ruedy, K., Ahmann, A., Bergenstal, R., Haller, S., Kollman, C., Kruger, D., McGill, J. B., Polonsky, W., et al. (2017) · JAMA · doi:10.1001/jama.2016.19975 · Cited by 1,185
Self-citationBolinder, J., Antuna, R., Geelhoed-Duijvestijn, P., Kröger, J., & Weitgasser, R. (2016) · The Lancet · doi:10.1016/s0140-6736(16)31535-5 · Cited by 893 · cited 2×
“severe hypoglycemia (26-37) [C,C,B,B,C,C,A,C,B,C,B].”
Garber, A. J., Abrahamson, M. J., Barzilay, J. I., Blonde, L., Bloomgarden, Z. T., Bush, M. A., Dagogo-Jack, S. E., DeFronzo, R. A., EINHORN, D. F., Fonseca, V. A., et al. (2016) · Endocrine Practice · doi:10.4158/ep151126.cs · Cited by 879
Self-citationVariability of Blood Glucose Concentration and Short-term Mortality in Critically Ill Patients
Egi, M., Bellomo, R., Stachowski, E., French, C., & Hart, G. K. (2006) · Anesthesiology · doi:10.1097/00000542-200608000-00006 · Cited by 853
Gold, A. E., Macleod, K. M., & Frier, B. M. (1994) · Diabetes Care · doi:10.2337/diacare.17.7.697 · Cited by 810
The barrier of hypoglycemia in diabetes
Cryer, P. E. (2008) · Diabetes · doi:10.2337/db08-1084 · Cited by 725
Flagged first, then by citations
2 of the 82 references couldn’t be matched to a known paper.
Cited by
Sorted by citations
Items 401–500 of 1,003
Foreman, Y. D., Brouwers, M. C. G. J., Berendschot, T. T. J. M., DONGEN, M. C. J. M. V., Eussen, S. J. P. M., van Greevenbroek, M. M. J., Henry, R. M. A., Houben, A. J. H. M., Kallen, C., Kroon, A. A., et al. (2019) · Cardiovascular Diabetology · doi:10.1186/s12933-019-0950-x · Cited by 32
Daily variations in sleep and glucose in adolescents with type 1 diabetes
Griggs, S. A., Redeker, N. S., Jeon, S., & Grey, M. J. (2020) · Pediatric Diabetes · doi:10.1111/pedi.13117 · Cited by 32
Danne, T., Schweitzer, M. A., Keuthage, W., Kipper, S., Kretzschmar, Y., Simon, J., Wiedenmann, T., & Ziegler, R. (2020) · Diabetes Technology & Therapeutics · doi:10.1089/dia.2020.0360 · Cited by 32
Self-citationKim, M. Y., Kim, G., Park, J. Y., Choi, M. S., Jun, J. E., Lee, Y., Jin, S., Hur, K. Y., & Kim, J. H. (2021) · Diabetes Technology & Therapeutics · doi:10.1089/dia.2020.0599 · Cited by 32
Current concepts and clinical importance of glycemic variability
Ravi, R., Balasubramaniam, V., Kuppusamy, G., & Ponnusankar, S. (2021) · Diabetes & Metabolic Syndrome Clinical Research & Reviews · doi:10.1016/j.dsx.2021.03.004 · Cited by 37
Clinical Application of Time in Range and Other Metrics
Aleppo, G. (2021) · Diabetes Spectrum · doi:10.2337/ds20-0093 · Cited by 32
Lee, H., Park, S., & Kim, E. Y. (2021) · Journal of Clinical Medicine · doi:10.3390/jcm10184078 · Cited by 34
Blood Glucose Monitoring in Adults and Children with Diabetes: Update 2021
CHENG, A. Y. Y., Feig, D. S., Ho, J., Siemens, R. L., BAJAJ, H. S., Gilbert, J. D., Houlden, R. L., Kim, J., MacKay, D., Rabi, D. M., et al. (2021) · Canadian Journal of Diabetes · doi:10.1016/j.jcjd.2021.07.003 · Cited by 36
Minimed Medtronic 780G optimizes glucose control in patients with type 1 diabetes mellitus
Pintaudi, B., Gironi, I., Nicosia, R., Meneghini, E., Disoteo, O., Mion, E., & Bertuzzi, F. (2022) · Nutrition Metabolism and Cardiovascular Diseases · doi:10.1016/j.numecd.2022.03.031 · Cited by 32
Sun, Y., Cano-Garcia, H., Kallos, E., O’Brien, F., Akintonde, A., Motei, D. E., Ancu, O., Mackenzie, R., & Kosmas, P. (2023) · IEEE Sensors Journal · doi:10.1109/jsen.2023.3293248 · Cited by 33
Prioleau, T., Bartolome, A., Comi, R. J., & Stanger, C. (2023) · Scientific Data · doi:10.1038/s41597-023-02469-5 · Cited by 42
Beato-Víbora, P. I. (2020) · Diabetes Technology & Therapeutics · doi:10.1089/dia.2020.0184 · Cited by 31
RetractedHypoglycemia event prediction from CGM using ensemble learning
Fleischer, J., Hansen, T. K., & Cichosz, S. L. (2022) · Frontiers in Clinical Diabetes and Healthcare · doi:10.3389/fcdhc.2022.1066744 · Cited by 32
Tan, Y. Y., Suan, E., Koh, G. C., Suhairi, S. B., & Tyagi, S. (2024) · Archives of Public Health · doi:10.1186/s13690-024-01459-2 · Cited by 37
Recent Updates on Type 1 Diabetes Mellitus Management for Clinicians
Iqbal, A., Novodvorský, P., & Heller, S. R. (2018) · Diabetes & Metabolism Journal · doi:10.4093/dmj.2018.42.1.3 · Cited by 37
Self-citationUnderstanding Continuous Glucose Monitoring Data
Bergenstal, R. (2018) · Role of Continuous Glucose Monitoring in Diabetes Treatment · doi:10.2337/db20181-20 · Cited by 37
Self-citationManaging free-living hyperglycemia with exercise or interrupted sitting in type 2 diabetes
Blankenship, J. M., Chipkin, S. R., Freedson, P. S., STAUDENMAYER, J. W., Lyden, K. A., & Braun, B. (2018) · Journal of Applied Physiology · doi:10.1152/japplphysiol.00389.2018 · Cited by 31
Singh, L. G., Levitt, D. L., Satyarengga, M., Pinault, L. F., Zhan, M., Sorkin, J. D., Fink, J. C., Umpierrez, G. E., & Spanakis, E. K. (2019) · Journal of Diabetes Science and Technology · doi:10.1177/1932296819889640 · Cited by 31
Chan, C. L., Pyle, L. L., Vigers, T., Zeitler, P. S., & Nadeau, K. J. (2021) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/clinem/dgab692 · Cited by 29
Jacobsen, L. M., Sherr, J. L., Considine, E. G., Chen, A., Peeling, S., Hulsmans, M., Charleer, S., Urazbayeva, M., Tosur, M., ALAMARIE, S. A., et al. (2023) · Communications Medicine · doi:10.1038/s43856-023-00358-x · Cited by 34
Self-citationContinuous glucose monitoring: transforming diabetes management step by step
Bergenstal, R. M. (2018) · The Lancet · doi:10.1016/s0140-6736(18)30290-3 · Cited by 33
Self-citationEnhancing the Capabilities of Continuous Glucose Monitoring With a Predictive App
Herrero, P., Andorrà, M., Babion, N., Bos, H., Koehler, M., Klopfenstein, Y., Leppäaho, E., Lustenberger, P., Peak, A., Ringemann, C., et al. (2024) · Journal of Diabetes Science and Technology · doi:10.1177/19322968241267818 · Cited by 31
Distinct patterns of daily glucose variability by pubertal status in youth with type 1 diabetes
Zhu, J., Volkening, L. K., & Laffel, L. M. (2020) · Diabetes Care · doi:10.2337/dc19-0083 · Cited by 30
Self-citationPrecision Dosing of Rapid-Acting Insulin Matters
Aanstoot, H., Rodriguez, H., WEINZIMER, S. A., Vint, N., & Koeneman, L. (2020) · Diabetes Technology & Therapeutics · doi:10.1089/dia.2019.0374 · Cited by 30
Self-citationCordero, T. L., Dai, Z., Arrieta, A., Niu, F., Vella, M., Shin, J., Rhinehart, A. S., MCVEAN, J. J. F., Lee, S. W., Slover, R. H., et al. (2023) · Diabetes Technology & Therapeutics · doi:10.1089/dia.2023.0123 · Cited by 33
Self-citationManov, A. E., Chauhan, S., Dhillon, G. S., Dhaliwal, A., Antonio, S., Donepudi, A., Jalal, Y., Nazha, J., Banal, M., & House, J. (2023) · Cureus · doi:10.7759/cureus.42545 · Cited by 30
Intensive Glycemic Treatment During Type 1 Diabetes Pregnancy: A Story of (Mostly) Sweet Success!
Murphy, H. R. (2018) · Diabetes Care · doi:10.2337/dci18-0001 · Cited by 30
Self-citationWei, W., Zhao, S., Fu, S.-L., Lan, Y., Mao, H., Tan, Q., Xu, P., & Yang, G. (2019) · Frontiers in Endocrinology · doi:10.3389/fendo.2019.00536 · Cited by 30
Personal Versus Professional Continuous Glucose Monitoring: When to Use Which on Whom
Longo, R. R., & Sperling, S. B. (2019) · Diabetes Spectrum · doi:10.2337/ds18-0093 · Cited by 30
Carlson, A. L., Criego, A. B., Martens, T. W., & Bergenstal, R. M. (2019) · Endocrinology and Metabolism Clinics of North America · doi:10.1016/j.ecl.2019.10.010 · Cited by 33
Self-citationBenefits and limitations of continuous glucose monitoring in type 1 diabetes
Stone, J. Y., & Bailey, T. S. (2020) · Expert Review of Endocrinology & Metabolism · doi:10.1080/17446651.2020.1706482 · Cited by 30
Assessment of Glucose Control Metrics by Discriminant Ratio
Moscardó, V., Herrero, P., Reddy, M., Hill, N. R., Georgiou, P., & Oliver, N. S. (2020) · Diabetes Technology & Therapeutics · doi:10.1089/dia.2019.0415 · Cited by 33
Sepúlveda, E., Poínhos, R., Nata, G., Carvalho, D. M., Neves, J. S., Seixas, D., Choudhary, P., Vicente, S., & Amiel, S. A. (2020) · Diabetes Technology & Therapeutics · doi:10.1089/dia.2020.0034 · Cited by 31
Self-citationCutruzzolà, A., Irace, C., Parise, M., Fiorentino, R., Tripodi, P. F. P., Ungaro, S., Babinsky, V. N., & Gnasso, A. (2020) · Nutrition Metabolism and Cardiovascular Diseases · doi:10.1016/j.numecd.2020.06.009 · Cited by 29
Tecce, N., Masulli, M., Lupoli, R., Pepa, G. D., Bozzetto, L., Palmisano, L., Rivellese, A. A., Riccardi, G., & Capaldo, B. (2020) · Cardiovascular Diabetology · doi:10.1186/s12933-020-01137-x · Cited by 34
Freckmann, G., Pleus, S., Schauer, S., Link, M., Jendrike, N. R. M., Waldenmaier, D., Haug, C., & Stuhr, A. (2021) · Experimental and Clinical Endocrinology & Diabetes · doi:10.1055/a-1347-2550 · Cited by 30
Varghese, J. S., Ho, J. C., Anjana, R. M., Pradeepa, R., Patel, S. A., Jebarani, S., Baskar, V., Narayan, K. M. V., & Mohan, V. (2021) · Diabetes Technology & Therapeutics · doi:10.1089/dia.2020.0672 · Cited by 30
Evidence of Early Diabetic Nephropathy in Pediatric Type 1 Diabetes
Mamilly, L., Mastrandrea, L. D., Vasquez, C. M., Klamer, B. G., Kallash, M., & Aldughiem, A. (2021) · Frontiers in Endocrinology · doi:10.3389/fendo.2021.669954 · Cited by 31
Closed-Loop Insulin Therapy in Older Adults with Type 1 Diabetes: Real-World Data
Toschi, E., Atakov-Castillo, A., Slyne, C., & Munshi, M. N. (2021) · Diabetes Technology & Therapeutics · doi:10.1089/dia.2021.0311 · Cited by 30
Captieux, M., Fleetwood, K., Kennon, B., Sattar, N. A., Lindsay, R. S., Guthrie, B., & Wild, S. H. (2021) · PLoS Medicine · doi:10.1371/journal.pmed.1003828 · Cited by 32
Scheinker, D., Gu, A., Grossman, J., Ward, A., Ayerdi, O., Miller, D., Leverenz, J. C., Hood, K. K., Lee, M. Y., Maahs, D. M., et al. (2022) · JMIR Diabetes · doi:10.2196/27284 · Cited by 31
Self-citationBerikov, V., Андреевна, К. О., Semenova, J. F., & Klimontov, V. V. (2022) · Journal of Personalized Medicine · doi:10.3390/jpm12081262 · Cited by 30
Cai, J., Yang, Q., Lu, J., Shen, Y., Wang, C., Chen, L., Zhang, L., Lu, W., Zhu, W., Xia, T., et al. (2022) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/clinem/dgac692 · Cited by 30
Clinical Approach to Flash Glucose Monitoring: An Expert Recommendation
Chico, A., Aguilera, E., Ampudia-Blasco, F., Bellido, V., Cardona-Hernández, R., Escalada, F. J., Fernández, D., Gómez-Peralta, F., de Villar, N. G. P., Gorgojo, J., et al. (2020) · Journal of Diabetes Science and Technology · doi:10.1177/1932296819841911 · Cited by 27
Huang, Y., Yue, L., Qiu, J., Gao, M., Liu, S., & Wang, J. (2022) · Hormone and Metabolic Research · doi:10.1055/a-1880-0978 · Cited by 31
Zang, L., Li, Y., Hao, H., Liu, J., Zhang, Q., Gao, F., Wang, H., Chen, Y., Gu, W., Du, J., et al. (2023) · Stem Cells Translational Medicine · doi:10.1093/stcltm/szad060 · Cited by 30
A foundation model for continuous glucose monitoring data
Lutsker, G., Sapir, G., Shilo, S., Merino, J., Godneva, A., Greenfield, J. R., Samocha‐Bonet, D., Dhir, R., Gude, F., Mannor, S., et al. (2026) · Nature · doi:10.1038/s41586-025-09925-9 · Cited by 64
Riddle, M. C., Gerstein, H. C., & Cefalu, W. T. (2017) · Diabetes Care · doi:10.2337/dci17-0049 · Cited by 30
Monnier, L., Colette, C., Schlienger, J.-L., Bauduceau, B., & Owens, D. R. (2019) · Diabetes & Metabolism · doi:10.1016/j.diabet.2019.01.007 · Cited by 29
Jangam, S. R., Dunn, T. C., Xu, Y., Hayter, G., & Ajjan, R. (2019) · BMJ Open Diabetes Research & Care · doi:10.1136/bmjdrc-2018-000611 · Cited by 29
Use of Diabetes Technology in Children
Desrochers, H. R., Schultz, A. T., & Laffel, L. M. (2020) · Endocrinology and Metabolism Clinics of North America · doi:10.1016/j.ecl.2019.11.001 · Cited by 29
Self-citationA systematic review on clinical implication of continuous glucose monitoring in diabetes management
Gillani, S. W., Azhar, A., Mohiuddin, G., & Majeed, R. A. (2020) · Journal of Pharmacy And Bioallied Sciences · doi:10.4103/jpbs.jpbs_7_20 · Cited by 29
Ogawa, W., Hirota, Y., Osonoi, T., Tosaki, T., Kato, Y., Utsunomiya, K., Nishimura, R., & Nakamura, J. (2020) · Journal of Diabetes Investigation · doi:10.1111/jdi.13327 · Cited by 30
Association of time in range with hemoglobin A1c, glycated albumin and 1,5‐anhydro‐ d ‐glucitol
Ohigashi, M., Osugi, K., Kusunoki, Y., Washio, K., Matsutani, S., Tsunoda, T., Matsuo, T., Konishi, K., Katsuno, T., Namba, M., et al. (2020) · Journal of Diabetes Investigation · doi:10.1111/jdi.13437 · Cited by 28
Consensus report: Definition and interpretation of remission in type 2 diabetes
Riddle, M. C., Cefalu, W. T., Evans, P. H., Gerstein, H. C., Nauck, M. A., Oh, W. K., Rothberg, A. E., le Roux, C. W., Rubino, F., Schauer, P. R., et al. (2021) · Diabetic Medicine · doi:10.1111/dme.14669 · Cited by 31
Xie, P., Deng, B., Zhang, X., Li, Y., Du, C., Rui, S., Deng, W., Boey, J., Armstrong, D. G., Ma, Y., et al. (2021) · Diabetes/Metabolism Research and Reviews · doi:10.1002/dmrr.3498 · Cited by 29
Hansen, E. A., Klee, P., Dirlewanger, M., Bouthors, T., Elowe-Gruau, É., Stoppa‐Vaucher, S., Phan-Hug, F., Antoniou, M.-C., Pasquier, J., Dwyer, A. A., et al. (2018) · Pediatric Diabetes · doi:10.1111/pedi.12723 · Cited by 28
Adolfsson, P., Rentoul, D., Klinkenbijl, B., & Parkin, C. G. (2018) · touchREVIEWS in Endocrinology · doi:10.17925/ee.2018.14.2.50 · Cited by 30
Self-citationAvari, P., Moscardó, V., Jugnee, N., Oliver, N. S., & Reddy, M. (2019) · Journal of Diabetes Science and Technology · doi:10.1177/1932296819867688 · Cited by 29
Navodnik, M. P., Janež, A., & Žuran, I. (2023) · Pharmaceutics · doi:10.3390/pharmaceutics15071945 · Cited by 28
Pediatric Medicaid Patients With Type 1 Diabetes Benefit From Continuous Glucose Monitor Technology
Ravi, S., Coakley, A., Vigers, T., Pyle, L. L., Forlenza, G. P., & Alonso, T. (2020) · Journal of Diabetes Science and Technology · doi:10.1177/1932296820906214 · Cited by 28
Continuous Glucose Monitoring–Derived Data Report—Simply a Better Management Tool
Battelino, T., & Bergenstal, R. M. (2020) · Diabetes Care · doi:10.2337/dci20-0032 · Cited by 27
Self-citationDave, D., Erraguntla, M., Lawley, M., DeSalvo, D. J., Haridas, B., McKay, S. V., & Koh, C. J. (2021) · JMIR Diabetes · doi:10.2196/26909 · Cited by 29
Varimo, T. J., Pulkkinen, M., Hakonen, E. T., Hero, M. T., Miettinen, P. J., & Tuomaala, A. (2021) · Pediatric Diabetes · doi:10.1111/pedi.13235 · Cited by 29
Variations in Sleep Characteristics and Glucose Regulation in Young Adults With Type 1 Diabetes
Griggs, S. A., Grey, M. J., Strohl, K. P., Crawford, S. L., Margevicius, S. P., Kashyap, S. R., Li, C.-S. R., Rajagopalan, S., & Hickman, R. L. (2021) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/clinem/dgab771 · Cited by 28
Santos, T. J. D., Dave, C., MacLeish, S. A., & Wood, J. (2021) · BMJ Open Diabetes Research & Care · doi:10.1136/bmjdrc-2021-002537 · Cited by 28
Psoma, O., Makris, M., Tselepis, A. D., & Tsimihodimos, V. (2022) · Journal of Diabetes Science and Technology · doi:10.1177/19322968221146808 · Cited by 32
Martin, C., Criego, A. B., Carlson, A. L., & Bergenstal, R. M. (2019) · Current Diabetes Reports · doi:10.1007/s11892-019-1177-7 · Cited by 30
Self-citationAcciaroli, G., Welsh, J. B., & Akturk, H. K. (2022) · Journal of Diabetes Science and Technology · doi:10.1177/1932296820982584 · Cited by 27
Zelicha, H., Yang, J., Henning, S. M., Huang, J., Lee, R., Thames, G., Livingston, E. H., Heber, D., & Li, Z. (2024) · American Journal of Clinical Nutrition · doi:10.1016/j.ajcnut.2024.01.008 · Cited by 36
BAJAJ, H. S., Ásbjörnsdóttir, B., Carstensen, L., Laugesen, C., Mathieu, C., Philis‐Tsimikas, A., & Battelino, T. (2024) · Diabetes Care · doi:10.2337/dc23-2136 · Cited by 27
Self-citationQi, L., Geng, X., Feng, R.-L., Wu, S., Fu, T., Li, N., Ji, H., Cheng, R., Wu, H., Wu, D., et al. (2024) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2024.111869 · Cited by 27
Cai, J., Liu, J., Lu, J., Ni, J., Wang, C., Chen, L., Lu, W., Zhu, W., Xia, T., & Zhou, J. (2025) · Diabetes Obesity and Metabolism · doi:10.1111/dom.16212 · Cited by 27
Banghøj, A. M., Krogager, C., Kristensen, P. L., Hansen, K. W., Laugesen, E., Fleischer, J., Cichosz, S. L., Poulsen, P. L., Kirkegaard, M. G., Thorsteinsson, B., et al. (2020) · Endocrinology Diabetes & Metabolism · doi:10.1002/edm2.148 · Cited by 26
Pleus, S., Stuhr, A., Link, M., Haug, C., & Freckmann, G. (2021) · Journal of Diabetes Science and Technology · doi:10.1177/1932296821992373 · Cited by 27
Furthner, D., Lukas, A., Schneider, A.-M., Mörwald, K., Maruszczak, K., Gombos, P., Gomahr, J., Steigleder‐Schweiger, C., Weghuber, D., & Pixner, T. (2021) · Nutrients · doi:10.3390/nu13103558 · Cited by 31
Opportunities and challenges in closed-loop systems in type 1 diabetes
Wilson, L. M., Jacobs, P. G., Riddell, M. C., Zaharieva, D. P., & Castle, J. R. (2021) · The Lancet Diabetes & Endocrinology · doi:10.1016/s2213-8587(21)00289-8 · Cited by 27
Olsen, M. T., Dungu, A. M., Klarskov, C. K., Jensen, A. K., Lindegaard, B., & Kristensen, P. L. (2022) · BMC Pulmonary Medicine · doi:10.1186/s12890-022-01874-7 · Cited by 27
Diabetes: the role of continuous glucose monitoring
Kluemper, J. R., Smith, A. C., & Wobeter, B. R. (2022) · Drugs in Context · doi:10.7573/dic.2021-9-13 · Cited by 30
Terahertz Asymmetric S-Shaped Complementary Metasurface Biosensor for Glucose Concentration
Al-Naib, I. A. I. (2022) · Biosensors · doi:10.3390/bios12080609 · Cited by 27
Software Packages and Tools for the Analysis of Continuous Glucose Monitoring Data
Piersanti, A., Giurato, F., Göbl, C. S., Burattini, L., Tura, A., & Morettini, M. (2022) · Diabetes Technology & Therapeutics · doi:10.1089/dia.2022.0237 · Cited by 31
Fonseca, L. M., Strong, R. W., Singh, S. M., Bulger, J., Cleveland, M. J., Grinspoon, E. A., Janess, K., Jung, L., Miller, K. M., Passell, E. J., et al. (2023) · JMIR Diabetes · doi:10.2196/39750 · Cited by 28
A Federated Learning-Inspired Evolutionary Algorithm: Application to Glucose Prediction
Falco, I. D., Cioppa, A. D., Koutný, T., Úbl, M., Krčma, M., Scafuri, U., & Tarantino, E. (2023) · Sensors · doi:10.3390/s23062957 · Cited by 30
Liang, X., Miao, Z., Lu, S., Ye, M., Wang, J., Zhao, H., Xiao, C., Shuai, M., Gou, W., Liang, Y., et al. (2023) · iMeta · doi:10.1002/imt2.96 · Cited by 27
Wang, Y., Lu, J., Ni, J., Wang, M., Shen, Y., Lu, W., Zhu, W., Bao, Y., Rodbard, D., Vigersky, R. A., et al. (2023) · Diabetes Obesity and Metabolism · doi:10.1111/dom.15068 · Cited by 29
Self-citationUnderstanding temporal changes and seasonal variations in glycemic trends using wearable data
Belsare, P. V., Bartolome, A., Stanger, C., & Prioleau, T. (2023) · Science Advances · doi:10.1126/sciadv.adg2132 · Cited by 28
Marchand, L., Reffet, S., Vouillarmet, J., Cugnet‐Anceau, C., Disse, E., & Thivolet, C. H. (2018) · Diabetes & Metabolism · doi:10.1016/j.diabet.2018.05.009 · Cited by 26
Jia, Y., Long, D., Yang, Y., Wang, Q., Wu, Q., & Zhang, Q. (2024) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2024.111757 · Cited by 30
A case study on using a large language model to analyze continuous glucose monitoring data
Healey, E., Tan, A. L. M., Flint, K. L., Ruiz, J., & Kohane, I. S. (2025) · Scientific Reports · doi:10.1038/s41598-024-84003-0 · Cited by 29
Ehrmann, D., Heinemann, L., Freckmann, G., Waldenmaier, D., Faber-Heinemann, G., & Hermanns, N. (2019) · Diabetes Technology & Therapeutics · doi:10.1089/dia.2018.0332 · Cited by 26
Self-citationLee, A. S., Way, K. L., Johnson, N. A., & Twigg, S. M. (2019) · Journal of Diabetes and its Complications · doi:10.1016/j.jdiacomp.2019.107514 · Cited by 26
Secher, A. L., Pedersen‐Bjergaard, U., Svendsen, O. L., Gade-Rasmussen, B., Almdal, T., RAIMOND, L. H., Vistisen, D., & Nørgaard, K. (2021) · Diabetologia · doi:10.1007/s00125-021-05555-8 · Cited by 26
Self-citationPros and cons of continuous glucose monitoring in the intensive care unit
Sun, M.-T., Li, I.-C., Lin, W., & Lin, G. (2021) · World Journal of Clinical Cases · doi:10.12998/wjcc.v9.i29.8666 · Cited by 26
Murillo, S., Brugnara, L., Servitja, J., & Novials, A. (2022) · Diabetes & Metabolism · doi:10.1016/j.diabet.2022.101361 · Cited by 28
The hypoglycaemia error grid: A UK-wide consensus on CGM accuracy assessment in hyperinsulinism
Worth, C., Dunne, M. J., Salomon‐Estebanez, M., Harper, S., Nutter, P. W., Dastamani, A., Senniappan, S., & Banerjee, I. (2022) · Frontiers in Endocrinology · doi:10.3389/fendo.2022.1016072 · Cited by 26
Matabuena, M., Pazos-Couselo, M., Alonso‐Sampedro, M., Fernández‐Merino, C., González‐Quintela, A., & Gudé, F. (2023) · Scientific Reports · doi:10.1038/s41598-023-40949-1 · Cited by 28
Aktürk, H. K., Battelino, T., Castañeda, J., Arrieta, A., van den Heuvel, T. R. A., & Cohen, O. (2024) · Diabetes Technology & Therapeutics · doi:10.1089/dia.2023.0432 · Cited by 26
Self-citationXu, Y., Tan, D. H. Y., & Lee, J. Y. (2019) · International Journal of Clinical Practice · doi:10.1111/ijcp.13357 · Cited by 26
Helleputte, S., Backer, T. L. M. D., Lapauw, B., Shadid, S., Celie, B. M., Eetvelde, B. V., Wyngaert, K. V., & Calders, P. (2020) · Diabetes/Metabolism Research and Reviews · doi:10.1002/dmrr.3301 · Cited by 26
Lu, Y., Liu, D., Liang, Z., Liu, R., Chen, P., Liu, Y., Li, J., Feng, Z., Li, L. M., Sheng, B., et al. (2025) · National Science Review · doi:10.1093/nsr/nwaf039 · Cited by 35
Self-citation
Metadata
- Authors
- Danne, T., Nimri, R., Battelino, T., Bergenstal, R. M., Close, K. L., DeVries, J. H., Garg, S., Heinemann, L., Hirsch, I., Amiel, S. A., Beck, R., Bosi, E., Buckingham, B., Cobelli, C., Dassau, E., Doyle, F. J., Heller, S., Hovorka, R., Jia, W., Jones, T., Kordonouri, O., Kovatchev, B., Kowalski, A., Laffel, L., Maahs, D., Murphy, H. R., Nørgaard, K., Parkin, C. G., Renard, E., Saboo, B., Scharf, M., Tamborlane, W. V., Weinzimer, S. A., & Phillip, M.
- Affiliations
- Kinderkrankenhaus auf der Bult (DE)
- Schneider Children's Medical Center (IL)
- University of Ljubljana (SI)
- Park Nicollet Health Services (US)
- Close Concerns (United States) (US)
- Amsterdam UMC Location University of Amsterdam (NL)
- University of Colorado Denver (US)
- Science & Co, Düsseldorf, Germany
- University of Washington (US)
- King's College London (GB)
- Jaeb Center for Health Research (US)
- Vita-Salute San Raffaele University (IT)
- Stanford Medicine (US)
- University of Padua (IT)
- Harvard University (US)
- University of Sheffield (GB)
- University of Cambridge (GB)
- Shanghai Jiao Tong University (CN)
- Telethon Kids Institute and School of Paediatrics and Child Health, The University of Western Australia, and Department of Endocrinology and Diabetes, Princess Margaret Hospital for Children, Perth, Australia
- University of Virginia (US)
- Breakthrough T1D (US)
- Joslin Diabetes Center (US)
- University of East Anglia (GB)
- Hvidovre Hospital (DK)
- CGParkin Communications, Boulder City, NV
- Department of Endocrinology, Diabetes, and Nutrition, Montpellier University Hospital, and Institute of Functional Genomics, University of Montpellier, and INSERM Clinical Investigation Centre, Montpellier, France
- DiaCare, Ahmedabad, Gujarat, India
- Hospital Nossa Senhora das Graças (BR)
- Yale University (US)
- Corresponding author
- Danne, Thomas
- ORCID
- Danne, Thomas
- Nimri, Revital
- Battelino, Tadej
- Bergenstal, Richard M.
- Close, Kelly L.
- DeVries, J. Hans
- Garg, Satish
- Heinemann, Lutz
- Hirsch, Irl
- Amiel, Stephanie A.
- Beck, Roy
- Bosi, Emanuele
- Buckingham, Bruce
- Cobelli, Claudio
- Dassau, Eyal
- Doyle, Francis J.
- Heller, Simon
- Hovorka, Roman
- Jia, Weiping
- Jones, Tim
- Kordonouri, Olga
- Kovatchev, Boris
- Kowalski, Aaron
- Laffel, Lori
- Maahs, David
- Murphy, Helen R.
- Nørgaard, Kirsten
- Parkin, Christopher G.
- Saboo, Banshi
- Tamborlane, William V.
- Weinzimer, Stuart A.
- Phillip, Moshe
- Venue
- Diabetes Care
- Publisher
- American Diabetes Association
- Published
- 2017-11-10
- Volume
- 40
- Issue
- 12
- Pages
- 1631-1640
- ISSN
- 0149-5992 (ISSN-L)
- 1935-5548
- PMC
- PMC6467165
- OpenAlex
- W2770616601
- Cited by
- 2,069
- References
- 82
- Citations by year
- 2026: 175 · 2025: 227 · 2024: 241 · 2023: 247 · 2022: 281 · 2021: 298 · 2020: 271 · 2019: 210 · 2018: 110 · 2017: 2
- FWCI
- 128.71
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Locations
- Diabetes Care (publishedVersion)
- Europe PMC (PubMed Central) (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- Pure Amsterdam UMC (publishedVersion, other-oa)
- Research at the University of Copenhagen (University of Copenhagen) (publishedVersion, other-oa)
- UWA Profiles and Research Repository (UWA) (submittedVersion)
- Data Archiving and Networked Services (DANS) (submittedVersion)
- HAL (submittedVersion)
- Archivio Istituzionale della Ricerca - Università Vita-Salute San Raffaele (submittedVersion)
- Apollo (University of Cambridge) (submittedVersion)
- Apollo
- Funders
- American Diabetes Association
- Abbott Laboratories
- Bristol-Myers Squibb
- Eli Lilly and Company
- AstraZeneca
- Sanofi
- Leona M. and Harry B. Helmsley Charitable Trust
- Bigfoot Biomedical
- Insulet Corporation
- Dexcom
- Jaeb Center for Health Research
- National Institute for Health and Care Research (NF-SI-0515-10079, CDF-2013-06-035)
- Bayer HealthCare
- Novo Nordisk
- Roche Diabetes Care
- Abbott Diabetes Care
- National Institute of Diabetes and Digestive and Kidney Diseases (P30DK116074)
- Topics
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Management and Research
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Treatment and Management
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Management and Education
- Keywords
- continuous glucose monitoring, glycemic control, HbA1c, HbA1c limitations, hypoglycemia, postprandial hyperglycemia, diabetes management, real-time CGM, diabetes complications, expert consensus recommendations
- MeSH terms
- Blood Glucose, Clinical Trials as Topic, Diabetes Mellitus, Type 1, Diabetes Mellitus, Type 2, Glycated Hemoglobin, Humans, Hyperglycemia, Hypoglycemia, Hypoglycemic Agents, Insulin, International Agencies, Physicians, Reference Standards, Research Personnel, Blood Glucose Self-Monitoring, Consensus
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
